{
    "2021-10-26": [
        [
            {
                "time": "",
                "original_text": "医药生物行业双周报：行业估值合理 择优布局优质标的",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业估值",
                        "布局",
                        "优质标的"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "人福医药所持光谷人福股份增至52.85%",
                "features": {
                    "keywords": [
                        "人福医药",
                        "光谷人福",
                        "股份增持"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}